Test is found sensitive, specific for Klinefelter's
June 1st 2005San Antonio--Methylation-specific polymerase chain reaction (M-PCR) is a sensitive, specific, fast, and relatively inexpensive method of diagnosing Klinefelter syndrome, according to data presented here by Cornell University researchers.
CMS proposes competitive acquisition program for injectables
June 1st 2005Washington--The federal government is proposing a new way to pay for injectable or intravenous drugs administered by physicians in their offices, but AUA says the plan is so confusing, burdensome, and administratively costly that it will not be used unless significant changes are made.
How to use US to guide periurethral collagen injection
June 1st 2005Periurethral bulking agents provide a unique, minimally invasive treatment option for stress urinary incontinence in female patients. Although many different injectable agents have been described, the gold standard remains glutaraldehyde cross-linked bovine collagen (Contigen). Limited efficacy and durability have been reported in a significant proportion of patients and presumed to result from collagen loss (eg, by tissue absorption/metabolism and luminal extravasation).
Endoscopic Tx of VUR shows cure rates above 90%
June 1st 2005Atlanta--Children treated with endoscopic intervention for vesicoureteral reflux continue to demonstrate cures that approach those of open surgery and have a high resolution rate after initial failure. In addition, incidence of febrile and non-febrile urinary tract infection after treatment is lower than after surgery, according to data presented here at the State-of-the-Art Symposium on Pediatric UTI, Reflux, Antibiotic Resistance, and Endoscopy.
Post-BCG cystectomy: Is 1 year too long to wait?
June 1st 2005Charleston, SC--Patients presenting with bladder cancer pose a difficult question for the urologists who must decide how to treat them. Bacillus Calmette-Guerin (Pacis, TherCys, TICE BCG) is an option to consider before cystectomy in some patients, but knowing when BCG is no longer effective and when to perform cystectomy remains a challenge.
FISH called effective screening tool for bladder Ca
June 1st 2005Charleston, SC--Fluorescent in situ hybridization (FISH) is an effective screening tool for patients who present with signs and symptoms of bladder cancer that warrant an investigation for malignancy, according to a new study from the Medical University of South Carolina. Analysis of the data collected in the study, led by MUSC urology chairman Thomas Keane, MD, showed FISH to be more sensitive than the customary method of cytology.
Stone disease: Not just a problem in men anymore?
June 1st 2005San Antonio--The prevalence of women being discharged for stone disease has increased in recent years, according to research presented at last month's AUA annual meeting. The rate discharges for men with stone disease over the same period increased slightly for renal calculi and decreased in the case of ureteral calculi.
Study shows genitofemoral grafts feasible during RP
June 1st 2005San Antonio--Genitofemoral (GF) nerve grafting during radical retropubic prostatectomy can be performed safely with a low risk of postoperative morbidity and shows promising efficacy for returning erectile function after surgery involving wide nerve resection, according to the results of a retrospective study.
VEGF expression may help explain RCC agressiveness
June 1st 2005San Antonio--A new study examining the expression of the vascular endothelial growth factor (VEGF) family of proteins in kidney cancer has yielded several important findings, including the identification of different expression profiles of VEGF proteins in clear cell and papillary type renal cell carcinoma.
Hereditary form of RCC is best treated aggresively
June 1st 2005San Antonio--A relatively new inherited syndrome known as hereditary leiomyomatosis and renal cell cancer (HLRCC) has a more aggressive clinical course than other hereditary renal cancer syndromes, and expectant management of even small HLRCC tumors is not recommended, according to a study presented at the AUA annual meeting here.
Prior cancer diagnosis ups future renal cancer risk
June 1st 2005San Antonio--Patients who have other primary cancers are at higher risk for being identified with a renal tumor. But while physicians should have a low threshold for looking for renal cancer, the risk is not high enough to warrant that all patients in this population should be screened, according to a new study.
ASC rule retains coverage for three urologic procedures
June 1st 2005Washington--Federal officials, after considering arguments and concerns presented by urologists and others, have decided to continue coverage for nearly 100 procedures performed in ambulatory surgical centers, including three urologic procedures, instead of removing them from the approved list as had been previously proposed.
Legislation would end Medicare/Medicaid funding for ED drugs
May 26th 2005Sen. Chuck Grassley (R-IA) proposed legislation Tuesday that would end federal funding for "lifestyle" drugs such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) to treat sexual and erectile dysfunction. Coverage would be provided if the drugs are prescribed for a purpose other than sexual performance.
Genetic test may provide simple method to diagnose Klinefelter's
May 26th 2005Methylation-specific polymerase chain reaction (M-PCR) is a sensitive, specific, fast, and relatively inexpensive method of diagnosing Klinefelter's syndrome, according to data presented here by Peter N. Schlegel, MD, and colleagues from Cornell University, New York.
Mid-term results of newer cooled TUMT device called 'encouraging'
May 26th 2005Midpoint results of a 5-year multi-center IDE study comparing a new cooled transurethral microwave thermotherapy device against the conventional 60-minute Targis treatment (both from Urologix, Minneapolis) were announced here on Wednesday, and the data appear promising.
VEGF expression may explain aggressiveness of renal cell cancers
May 25th 2005A new study examining the expression of the vascular endothelial growth factor (VEGF) family of proteins in kidney cancer has yielded several important findings, including the identification of different expression profiles of VEGF proteins in clear cell and papillary type renal cell carcinoma.
Prior cancer diagnosis ups future renal cancer risk
May 25th 2005Patients who have other primary cancers have increased risk for renal cancer, the authors of a retrospective study reported yesterday. But while physicians should be alert to the possibility of renal cancer, the risk is not high enough to warrant that all patients in this population should be screened, the authors advise.
Hereditary form of RCC best treated aggressively, study shows
May 25th 2005An inherited syndrome known as hereditary leiomyomatosis and renal cell cancer (HLRCC) has a more aggressive clinical course than other hereditary renal cancer syndromes, according to a new study. The authors recommend surgical therapy early in the course of treatment of HLRCC patients rather than expectant management.
VEGF expression may explain aggressiveness of renal cell cancers
May 25th 2005A new study examining the expression of the vascular endothelial growth factor (VEGF) family of proteins in kidney cancer has yielded several important findings, including the identification of different expression profiles of VEGF proteins in clear cell and papillary type renal cell carcinoma.
Microsurgical varicocelectomy preferred over conservative treatment
May 25th 2005Men who experience painful recurrent varicoceles after undergoing conservative treatment and failed surgical repair are best served by microsurgical varicocelectomy, according to Canadian researchers.Of 11 men who had failed standard varicocelectomy and experienced pain before and after surgery, 10 experienced a favorable response following microsurgical repair, according to investigators."In my mind, microsurgical varicocelectomy is the gold standard, and non-microsurgical repair is sub-standard," said lead author Armand Zini, MD, associate professor of urology at McGill University, Montreal. "However, few urologists are able to perform this procedure, since they have not been trained properly."
Stone disease: Not just a problem in men anymore?
May 25th 2005The prevalence of women being discharged for stone disease has increased in recent years, according to research presented here yesterday. The rate of discharges for men with stone disease over the same period increased slightly for renal calculi and decreased in the case of ureteral calculi.